Stock comparison
Elevance Health
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ELV
Elevance Health
Market cap
$85.71B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ELV | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 35D | 71B | UTHR |
| Benjamin Graham | 52C | 76B | UTHR |
| Philip Fisher | 17F | 76B | UTHR |
| Peter Lynch | 21F | 62C | UTHR |
| Joel Greenblatt | 28F | 46D | UTHR |
| Charlie Munger | 24F | 64C | UTHR |
| Terry Smith | 19F | 64C | UTHR |
Side-by-side metrics
| Metric | ELV | UTHR |
|---|---|---|
| Market cap | $85.71B | $24.13B |
| P/E (TTM) | 16.5x | 19.2x |
| EV/EBIT | 13.2x | 15.2x |
| ROIC (TTM) | 7.91% | 18.81% |
| Gross margin | 23.16% | 86.58% |
| Net margin | 2.62% | 40.61% |
| Revenue CAGR 5y | 9.47% | 17.22% |
| EPS CAGR 5y | -0.07% | 29.84% |
| Debt / Equity | 0.7x | - |
| Dividend yield | 1.74% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ELV leads on
- Dividend yield1.74%vs 0.0%+100%
- Market cap$85.71Bvs $24.13B+72%
- P/E (TTM)16.5xvs 19.2x+14%
- EV/EBIT13.2xvs 15.2x+13%
UTHR leads on
- EPS CAGR 5y29.84%vs -0.07%+100%
- Debt / Equity-vs 0.7x+100%
- Net margin40.61%vs 2.62%+94%
- Gross margin86.58%vs 23.16%+73%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.